Glucosamine
Market: Snapshot
The glucosamine
market may gain phenomenal growth across the assessment period of
2020-2030 on the back of the escalating cases of arthritis globally. In
addition, the heightening number of the obese populace may further strengthen
the growth rate of the glucosamine market during the forecast period.
According to the Centers for Disease Control and Prevention
(CDC), from the tenure of 2013-2015, nearly 54.4 mn adults in the U.S. had been
told by the doctor that they had some form of arthritis. The CDC also predicts
that by the year 2040, over 78 mn (26 percent) U.S. adults from the age of 18
and above will have doctor-diagnosed arthritis. These statistics state the
growing influence of arthritis and the urgent need to cure it.
Obesity is also a grave problem worldwide. According to the
World Health Organization (WHO), in 2016, more than 1.9 bn adults above 18
years of age were obese. These numbers are expected to rise in the near future
due to the rapidly changing lifestyle. Hence, all these aspects indicate that
the glucosamine market may harness promising growth during the assessment
period.
Glucosamine is a compound that occurs naturally within the
cartilage of the joints. It is made from a blend of the chains of sugar and
proteins. Glucosamine is generally derived from the shells of the shellfish. It
is available in the form of capsules, powder, tablets, gel, and others. It is
one of the most common dietary supplements used across humans and pets too.
Hence all these aspects bring tremendous growth prospects for the glucosamine market.
Request Sample
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=80129
This report on the glucosamine market aids the stakeholder to
overcome the barriers of fake information and offers a detailed analysis of a
plethora of segments. The report provides the 3M (Market trends, Manufacturer
analysis. Minute study on regions) advantage to the stakeholder. This advantage
proves to be a game-changer for the stakeholder and assures ideal information
on all aspects surrounding the glucosamine market.
The report focuses on the impact of the SARS-CoV-2 outbreak and
also on the threats that may harm the growth prospects of the glucosamine market.
The scrutinized study conducted by the researchers also highlights the
opportunities and challenges that the glucosamine market may face during the
tenure of 2020-2030.
More
Trending Reports
Glucosamine
Market: Industrial Analysis
The glucosamine market comprises a large number of players
across the horizon. The players are always involved in novel product launches
and upgrades in glucosamine to attract a massive consumer base. The players
invest heavily in research and development activities for discovering new
formulations and techniques that will make glucosamine more effective for the
end-users.
The players are involved in expansion activities for seamlessly
catering to the overwhelming demand. Some well-entrenched players in the
glucosamine market are Teva Pharmaceutical Industries Ltd., NOW Health Group,
Inc., G.T.C. Union Group Ltd., Mylan N.V., Health World Ltd., and Foodchem
International Corporation.
Request
Covid19 analysis on this market
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=80129
Glucosamine
Market: Overwhelming Use across Various End-Uses
The glucosamine market may gain great growth on the back of the
rising cases of obesity and arthritis. In addition to food supplements,
glucosamine is also used in cosmetics. Glucosamine is also used as a key
ingredient in pet foods to relieve aging dogs from joint pain. These factors
may further invite immense growth prospects for the glucosamine market.
Glucosamine
Market: Regional Prospects
North America’s glucosamine market may record exponential growth
across the assessment period of 2020-2030. The rising number of people
consuming dietary supplements is increasing rapidly. This aspect may prove to
be a significant growth factor for the glucosamine market in North America.
The common use of glucosamine as an over-the-counter
prescription drug in developed countries across Europe may generate promising
growth for the glucosamine market. Thus, Europe may contribute to the growth of
the glucosamine market to a certain extent.
Buy Now
Comments
Post a Comment